Experimental and Molecular Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 17.5 | Q1 | 98.4% | 5.123 | Q1 | 99.1% |
| 2024 | 12.9 | Q1 | 96.4% | 4.001 | Q1 | 98.6% |
| 2023 | 9.5 | Q1 | 92.1% | 3.671 | Q1 | 98.5% |
| 2022 | 12.8 | Q1 | 95.3% | 3.380 | Q1 | 98.4% |
| 2021 | 12.2 | Q1 | 92.6% | 2.645 | Q1 | 97.5% |
| 2020 | — | — | 2.703 | Q1 | 97.4% | |
| 2019 | — | — | 2.136 | Q1 | 96.1% | |
| 2018 | — | — | 2.019 | Q1 | 95.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2092-6413
ISSN
1226-3613
country
GBcoverage
1996-2026